120 related articles for article (PubMed ID: 38163601)
1. Long-term MNNG exposure promotes gastric carcinogenesis by activating METTL3/m6A/miR1184 axis-mediated epithelial-mesenchymal transition.
Liu T; Feng YL; Wang RY; Yang S; Ge YL; Zhang TY; Li J; Li CY; Ruan Y; Luo B; Liang GY
Sci Total Environ; 2024 Feb; 913():169752. PubMed ID: 38163601
[TBL] [Abstract][Full Text] [Related]
2. Depicting the Profile of METTL3-Mediated lncRNA m6A Modification Variants and Identified SNHG7 as a Prognostic Indicator of MNNG-Induced Gastric Cancer.
Liu T; Feng Y; Yang S; Ge Y; Zhang T; Li J; Li C; Ruan Y; Luo B; Liang G
Toxics; 2023 Nov; 11(11):. PubMed ID: 37999596
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
4. miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2.
Yang Q; Xu E; Dai J; Wu J; Zhang S; Peng B; Jiang Y
Toxicol Lett; 2014 Aug; 228(3):147-56. PubMed ID: 24821435
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
6. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis.
Song C; Zhou C
J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m
Ji G; Wang X; Xi H
Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.
Wang G; Zhang Z; Xia C
Bioengineered; 2021 Dec; 12(2):9678-9691. PubMed ID: 34842045
[TBL] [Abstract][Full Text] [Related]
9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
10. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
11. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
12. miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway.
Jiang W; Lu W; Liu J; Ren H; Zhao X; Yang W
Toxicol Lett; 2024 Feb; 392():64-74. PubMed ID: 38184286
[TBL] [Abstract][Full Text] [Related]
13. Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells.
Lin L; Wei H; Yi J; Xie B; Chen J; Zhou C; Wang L; Yang Y
J Cell Biochem; 2019 Oct; 120(10):17635-17649. PubMed ID: 31209915
[TBL] [Abstract][Full Text] [Related]
14. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
15. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
16. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m
He H; Wu W; Sun Z; Chai L
Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342
[TBL] [Abstract][Full Text] [Related]
17. Silencing of METTL3 prevents the proliferation, migration, epithelial-mesenchymal transition, and renal fibrosis of high glucose-induced HK2 cells by mediating WISP1 in m6A-dependent manner.
Chen Y; Li P; Lin M; Jiang Y; Tan G; Huang L; Song D
Aging (Albany NY); 2024 Jan; 16(2):1237-1248. PubMed ID: 38289593
[TBL] [Abstract][Full Text] [Related]
18. Hesperidin Reversed Long-Term
Liang Z; Song J; Xu Y; Zhang X; Zhang Y; Qian H
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558440
[TBL] [Abstract][Full Text] [Related]
19. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3).
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Bioengineered; 2021 Dec; 12(1):1150-1160. PubMed ID: 33818282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
